Tofacitinib
NDC 42799-970, Tofacitinib, tablet, film coated, extended release, from Edenbridge Pharmaceuticals LLC..
- Product NDC
- 42799-970
- Status
- Listed
- Labeler
- Edenbridge Pharmaceuticals LLC.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218668
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42799-970 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE11 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42799-970-30 | 42799097030 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42799-970-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/576722e5-6639-452d-a5c3-33a064f19481NADAC price for package 42799097030
GET /v1/drugs/nadac/42799097030
Use it
Look up 42799-970 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42799-970 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42799-970. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.